/cloudfront-us-east-2.images.arcpublishing.com/reuters/AL3CPVT54FLNVEHXRES25RDE5E.jpg)
Celltrion says trial shows antibody COVID-19 treatment to be safe and effective - Reuters
6:51pm PDT - June 13th, 2021 business - ReutersSouth Korean drugmaker Celltrion Inc (068270.KS) on Monday announced positive results for its experimental antibody COVID-19 treatment that it said was safe and reduced the treatment period by nearly five days in Phase 3 global clinical trials.